Skip to content

The effect of remifentanil infusion on the incidence of postoperative chronic pain, a randomized, single blind controlled trial in thoracoscopic surgery

The effect of remifentanil infusion on the incidence of postoperative chronic pain, a randomized, single blind controlled trial in thoracoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117171
Enrollment
Unknown
Registered
2026-01-20
Start date
2024-09-17
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative chronic pain

Interventions

trial group:Pump remifentanil during surgery
control group:Do not use remifentanil during surgery

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: Men and women over the age of 18 2: ASA classification is grade I, II, or III 3: patients who will undergo thoracoscopic surgery under general anesthesia 4: patients understand this study clearly,voluntarily participate in, and sign an informed consent form by themselves

Exclusion criteria

Exclusion criteria: 1: Patients have a history of chronic pain or acute pain before surgery 2: Patients have been taking painkillers for a long time 3: Patients have severe liver and kidney dysfunction 4: Patients are in a state of depression and anxiety 5: Patients are pregnant or lactating women 6: Patients are allergic to the drugs involved in the study 7: Patients have participated in other drug clinical trials as a subject within the past 3 months 8: Researcher consider that patients should not participate in this trial

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative chronic pain;

Secondary

MeasureTime frame
Postoperative acute pain score;The quality of sleep;Anxiety and Depression score;

Countries

China

Contacts

Public ContactXie,Yegong

Tianjin Medical University General Hospital

xieyegongstudy@sina.com+86 139 0205 7574

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026